Evidence map›Paper›PMID 38048026›Full record

ArticleJournal of epidemiology and global health2024

Tuberculosis in Ukrainian War Refugees and Migrants in the Czech Republic and Slovakia: A Molecular Epidemiological Study.

Matúš Dohál, Věra Dvořáková, Miluše Šperková, Martina Pinková, Arash Ghodousi, Maryam Omrani, Igor Porvazník, Erik Michael Rasmussen, Mária Škereňová, Michaela Krivošová and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of epidemiology and global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Tuberculosis: An Ongoing Global Threat.Advances in experimental medicine and biology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Matúš DohálComenius University Bratislava, Malá Hora 4A, 036 01, Martin, Slovak Republic. matus.dohal@uniba.sk.
Věra DvořákováNational Institute of Public Health, Prague, Czech Republic.
Miluše ŠperkováNational Institute of Public Health, Prague, Czech Republic.
Martina PinkováNational Institute of Public Health, Prague, Czech Republic.
Arash GhodousiIRCCS San Raffaele Scientific Institute, Milan, Italy.
Maryam OmraniIRCCS San Raffaele Scientific Institute, Milan, Italy.
Igor PorvazníkNational Institute of Tuberculosis, Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovak Republic.
Erik Michael RasmussenStatens Serum Institut, Copenhagen, Denmark.
Mária ŠkereňováComenius University Bratislava, Malá Hora 4A, 036 01, Martin, Slovak Republic.
Michaela KrivošováComenius University Bratislava, Malá Hora 4A, 036 01, Martin, Slovak Republic.
Jiří WallenfelsUniversity Hospital Bulovka, Prague, Czech Republic.
Olha KonstantynovskaV.N. Karazin Kharkiv National University, Kharkiv, Ukraine.
Timothy M WalkerOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Vladyslav NikolayevskyyImperial College London, London, UK.
Daniela Maria CirilloIRCCS San Raffaele Scientific Institute, Milan, Italy.
Ivan SolovičNational Institute of Tuberculosis, Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovak Republic.
Juraj MokrýComenius University Bratislava, Malá Hora 4A, 036 01, Martin, Slovak Republic.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThe war in Ukraine has led to significant migration to neighboring countries, raising public health concerns. Notable tuberculosis (TB) incidence rates in Ukraine emphasize the immediate requirement to prioritize approaches that interrupt the spread and prevent new infections.

methodsWe conducted a prospective genomic surveillance study to assess migration's impact on TB epidemiology in the Czech Republic and Slovakia. Mycobacterium tuberculosis isolates from Ukrainian war refugees and migrants, collected from September 2021 to December 2022 were analyzed alongside 1574 isolates obtained from Ukraine, the Czech Republic, and Slovakia.

resultsOur study revealed alarming results, with historically the highest number of Ukrainian tuberculosis patients detected in the host countries. The increasing number of cases of multidrug-resistant TB, significantly linked with Beijing lineage 2.2.1 (p < 0.0001), also presents substantial obstacles to control endeavors. The genomic analysis identified the three highly related genomic clusters, indicating the recent TB transmission among migrant populations. The largest clusters comprised war refugees diagnosed in the Czech Republic, TB patients from various regions of Ukraine, and incarcerated individuals diagnosed with pulmonary TB specialized facility in the Kharkiv region, Ukraine, pointing to a national transmission sequence that has persisted for over 14 years.

conclusionsThe data showed that most infections were likely the result of reactivation of latent disease or exposure to TB before migration rather than recent transmission occurring within the host country. However, close monitoring, appropriate treatment, careful surveillance, and social support are crucial in mitigating future risks, though there is currently no evidence of local transmission in EU countries.

Indexed as

Molecular EpidemiologyMycobacterium tuberculosisRefugeesTransients and MigrantsTuberculosisAdolescentAdultArmed ConflictsCzech RepublicFemaleHumansIncidenceMaleMiddle AgedProspective StudiesSlovakiaControl of tuberculosisMigrationRefugeesTuberculosis epidemiology

Identifiers

PMID38048026
PMCPMC11043285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.